LUP.F - Luye Pharma Group Ltd.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Currency in EUR

Valuation Measures

Market Cap (intraday) 52.3B
Enterprise Value 32.23B
Trailing P/E 12.66
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.04
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 0.99
52-Week Change 3-17.56%
S&P500 52-Week Change 31.68%
52 Week High 30.8757
52 Week Low 30.5450
50-Day Moving Average 30.6624
200-Day Moving Average 30.6952

Share Statistics

Avg Vol (3 month) 31.14k
Avg Vol (10 day) 3N/A
Shares Outstanding 53.27B
Float 1.72B
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.01
Forward Annual Dividend Yield 41.95%
Trailing Annual Dividend Rate 30.01
Trailing Annual Dividend Yield 31.95%
5 Year Average Dividend Yield 4N/A
Payout Ratio 422.27%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 14, 2019
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 25.19%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)6.30%
Return on Equity (ttm)17.61%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)51.20%
Gross Profit (ttm)4.05B
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)0.0550
Quarterly Earnings Growth (yoy)24.20%

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)77.36
Current Ratio (mrq)1.06
Book Value Per Share (mrq)0.34

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A